Get the Stockscreener App
0.618
0.82%
-0.0051
Gt Biopharma Inc stock is traded at $0.618, with a volume of 227.10K.
It is down -0.82% in the last 24 hours and down -3.23% over the past month.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
See More
Previous Close:
$0.6231
Open:
$0.605
24h Volume:
227.10K
Relative Volume:
0.14
Market Cap:
$2.20M
Revenue:
-
Net Income/Loss:
$-9.64M
P/E Ratio:
-0.0893
EPS:
-6.9236
Net Cash Flow:
$-10.11M
1W Performance:
-7.32%
1M Performance:
-3.23%
6M Performance:
-73.48%
1Y Performance:
-79.74%
1-Day Range:
$0.60
$0.623
1-Week Range:
$0.587
$0.6731
52-Week Range:
$0.55
$4.10
Gt Biopharma Inc Stock (GTBP) Company Profile
Name
Gt Biopharma Inc
Sector
Industry
Phone
(800) 304-9888
Address
505 MONTGOMERY STREET, SAN FRANCISCO
Compare GTBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.50 | 4.21B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.99 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.825 | 217.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2288 | 502.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.3695 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | ROTH MKM | Buy |
| May-24-21 | Initiated | H.C. Wainwright | Buy |
| Apr-13-21 | Initiated | B. Riley Securities | Buy |
| Mar-17-21 | Initiated | ROTH Capital | Buy |
Gt Biopharma Inc Stock (GTBP) Latest News
Will GT Biopharma Inc. bounce back from current supportWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Combining machine learning predictions for GT Biopharma Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com
Real time breakdown of GT Biopharma Inc. stock performance2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
What institutional flow reveals about GT Biopharma Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - newser.com
Understanding GT Biopharma Inc.’s price movementPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
Short interest data insights for GT Biopharma Inc.2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
Evaluating GT Biopharma Inc. with trendline analysisWeekly Gains Summary & Safe Entry Point Identification - newser.com
Will GT Biopharma Inc. stock benefit from automation2025 Big Picture & Short-Term High Return Strategies - newser.com
Will GT Biopharma Inc. (OXIA) stock test record highs in 2025Analyst Downgrade & Risk Managed Investment Signals - newser.com
Is GT Biopharma Inc. stock ready for breakoutJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Using R and stats models for GT Biopharma Inc. forecastingJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
Can GT Biopharma Inc. stock sustain free cash flow growthJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak - MSN
News impact scoring models applied to GT Biopharma Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
EBITDA of GT Biopharma, Inc. – BOATS:GTBP - TradingView
GT Biopharma, Inc. (GTBP) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
GT Biopharma, Inc. (GTBP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Applying chart zones and confluence areas to GT Biopharma Inc.M&A Rumor & AI Driven Price Forecasts - newser.com
Tools to monitor GT Biopharma Inc. recovery probabilityQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Analyzing recovery setups for GT Biopharma Inc. investorsSell Signal & Real-Time Buy Zone Alerts - newser.com
Gt Biopharma Inc Stock (GTBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):